Cleveland Clinic researchers are three years into a longitudinal brain study, in which volunteers are undergoing periodic medical imaging, cognitive assessments and neuropsychological exams to help ...

MC Joseph, a 78-year-old prostate cancer survivor, experienced debilitating tremors due to Parkinson's disease. After ...

Currently, diagnosing Parkinson’s disease can be a challenging process ... Imaging technologies such as DaTscan and MRI may also be used to observe brain changes associated with the disease.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients. Weekly injections of the GLP-1 receptor agonist exenatide (Byetta, ...

Berlin, Germany, and Research Triangle Park, N.C., USA, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Not intended for UK MediaRegenerative Medicine ...

Researchers led by Zhentao Zhang at Wuhan University, China have discovered a cholesterol metabolite that plays a critical role in the development of Parkinson's disease in mice.

Researchers at Oregon Health & Science University (OHSU) are leading a study looking at a possible link between thrashing sleep and Parkinson's disease. Veterans diagnosed ... adults willing to ...

Exenatide had no disease-modifying effects in a phase 3 trial Parkinson’s disease, despite earlier evidence from a phase 2 study suggesting a potential role for GLP-1 agonists in PD.

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

People with Parkinson's disease are more likely to develop certain types of dementia. Find out about the causes, symptoms and treatments. Parkinson’s disease is a brain disease that affects around 145 ...

AskBio’s gene therapy AB-1005 to treat Parkinson’s disease receives US FDA Regenerative Medicine Advanced Therapy designation: Berlin, Germany Thursday, February 20, 2025, 10: ...